- ProductsInvestment SuiteExclusiveFeatures
- PlatformTrading PlatformsFeatures and ToolsCalculatorsPricing
- ResearchResearch CallsResearch Reports
- MarketStocksIndicesMutual FundsIPO
- LearnStockshaalaResourceInvesting GuideEvents
- Partner
- Support
Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 1.82 | 1.94 |
NAV | ₹499.68 | ₹422.46 |
Fund Started | 10 May 2004 | 04 Jun 1999 |
Fund Size | ₹8080.97 Cr | ₹3610.51 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
1.82
1.94
NAV
₹499.68
₹422.46
Fund Started
10 May 2004
04 Jun 1999
Fund Size
₹8080.97 Cr
₹3610.51 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 16.36% | 22.10% |
3 Year | 20.14% | 24.10% |
5 Year | 22.69% | 24.77% |
1 Year
16.36%
22.10%
3 Year
20.14%
24.10%
5 Year
22.69%
24.77%
Holding Analysis
Equity | 99.48% | 96.93% |
Cash | 0.52% | 2.99% |
Equity
99.48%
96.93%
Cash
0.52%
2.99%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.43% |
Divi's Laboratories Ltd. | 9.28% |
Lupin Ltd. | 7.27% |
Cipla Ltd. | 5.71% |
Apollo Hospitals Enterprise Ltd. | 5.31% |
Dr. Reddy's Laboratories Ltd. | 5.19% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.61% |
Vijaya Diagnostic Centre Ltd. | 3.53% |
Abbott India Ltd. | 3.46% |
Medplus Health Services Ltd. | 3.41% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 13.45% |
Max Healthcare Institute Ltd. | 6.68% |
Divi's Laboratories Ltd. | 6.00% |
Cipla Ltd. | 4.79% |
Lupin Ltd. | 4.72% |
Lonza Group Ag | 4.38% |
Mankind Pharma Ltd. | 3.76% |
Krishna Institute of Medical Sciences Ltd | 3.72% |
Jupiter Life Line Hospitals Ltd. | 3.54% |
Ami Organics Ltd. | 3.38% |
Fund Manager
Name | Akshay Sharma | Tanmaya Desai |
Start Date | 01 Dec 2022 | 27 Jun 2011 |
Name
Akshay Sharma
Tanmaya Desai
Start Date
01 Dec 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 10 May 2004 | 04 Jun 1999 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
10 May 2004
04 Jun 1999